CME Q3 FY2026 earnings call — BigGo Finance
CME Group reported Q3 FY2026 revenue of $1.7B, up 13% YoY, with record ADV of 29.4M contracts. Adjusted EPS rose 13% to $3.02. All asset classes saw double-digit volume growth. Management expects record 2026 performance and highlighted new products and pricing changes. CME returned nearly $1B to shareholders.
How this was made
The 30-second read
Why it matters
Earnings beat and record volume suggest continued market share gains for CME, potentially driving stock appreciation.
Market read
CME's strong earnings reinforce its dominant position in the derivatives market, likely influencing related financial stocks.
What to watch
Regulatory review of Compute Futures and litigation over perpetual futures could pose headwinds.
Background
CME Group's Q3 FY2026 earnings call disclosed record financial results and operational metrics.
Ticker impact
CME Group reported record Q3 FY2026 revenue of $1.7B, 13% YoY growth and adjusted EPS of $3.02.
upward pressure as investors price in the earnings beat and record revenue.
Revenue and EPS both exceeded prior guidance, and record ADV indicates durable growth.
Market effects
Positive earnings may lift other exchange and clearing firms and boost market data providers.
Strong U.S. market data revenue supports broader financial services sector.
Record international ADV highlights CME's global footprint, benefiting global traders.
Counterpoint
If pricing changes in October offset growth, the rally could be limited.
Key entities
- companyCME Group Inc.
Leading derivatives exchange and clearinghouse.



